olympic semaglutide FDA Warns on Certain Forms of Compounded Semaglutide

What caught my attention wasn't just the number. It was what the number represents. New Phase 3 trial data for retatrutide showed an average weight loss of 28.3% at the highest dose,

27.44

★★★★☆4.6 (19)

The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight-loss results, Retatrutide

26.63

★★★★★4.3 (44)

Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation

20.74

★★★★★4.3 (42)

🚨 Retatrutide Phase 2 is out: 24.2% mean weight loss and a quarter lost >30%! Women lost more weight than men. #ADA2023 was like drinking from a fire hose for emerging anti-obesity

25.50

★★★★★4.4 (275)

SAHPRA's position on Semaglutide compounded products

26.33

★★★★★4.7 (226)

Retatrutide FDA Approval Status: July 2026 Update

26.56

★★★★★4.1 (111)

South Africans are being urged to obtain their medicines through legitimate healthcare channels. It has caused concerns about counterfeit, unregistered and illicit products entering the market. Regulators warn those medicines may not

21.49

★★★★★4.4 (160)